NASDAQ:VREX • US92214X1063
The current stock price of VREX is 10.81 USD. Today VREX is down by -0.46%. In the past month the price decreased by -19.21%. In the past year, price decreased by -13.52%.
ChartMill assigns a technical rating of 0 / 10 to VREX. When comparing the yearly performance of all stocks, VREX is a bad performer in the overall market: 76.83% of all stocks are doing better.
ChartMill assigns a fundamental rating of 4 / 10 to VREX. While VREX is still in line with the averages on profitability rating, there are concerns on its financial health.
On February 10, 2026 VREX reported an EPS of 0.19 and a revenue of 209.60M. The company beat EPS expectations (40.06% surprise) and missed revenue expectations (-1.06% surprise).
11 analysts have analysed VREX and the average price target is 19.18 USD. This implies a price increase of 77.39% is expected in the next year compared to the current price of 10.81.
For the next year, analysts expect an EPS growth of 3.8% and a revenue growth 4.48% for VREX
Over the last trailing twelve months VREX reported a non-GAAP Earnings per Share(EPS) of 1. The EPS increased by 78.57% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -6.17% | ||
| ROE | -14.2% | ||
| Debt/Equity | 0.78 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 18.81 | 187.913B | ||
| ISRG | INTUITIVE SURGICAL INC | 46.2 | 170.203B | ||
| SYK | STRYKER CORP | 22.27 | 129.047B | ||
| BSX | BOSTON SCIENTIFIC CORP | 19.77 | 101.721B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.52 | 49.099B | ||
| IDXX | IDEXX LABORATORIES INC | 38.71 | 45.48B | ||
| BDX | BECTON DICKINSON AND CO | 11.69 | 45.453B | ||
| RMD | RESMED INC | 18.8 | 33.857B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.69 | 32.053B | ||
| DXCM | DEXCOM INC | 25.27 | 25.116B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.99 | 18.115B | ||
| HOLX | HOLOGIC INC | 15.3 | 16.79B | ||
| PODD | INSULET CORP | 34 | 16.619B |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Varex Imaging Corp. engages in the design, manufacture, and sale of imaging components. The company is headquartered in Salt Lake City, Utah and currently employs 2,400 full-time employees. The company went IPO on 2017-01-20. The Company’s segments include Medical and Industrial. Its Medical segment designs, manufactures, sells and services X-ray imaging components, including X-ray tubes, flat panel and photon-counting detectors and accessories, high-voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and coolers. Its Industrial segment designs, develops, manufactures, sells, and services X-ray imaging products for use in a number of applications, including security applications for cargo screening at ports and borders, baggage screening at airports, and nondestructive testing, irradiation, and inspection applications used in a number of other verticals.
IPO: 2017-01-20
VAREX IMAGING CORP
1678 S Pioneer Rd
Salt Lake City UTAH 84104 US
CEO: Sunny S. Sanyal
Employees: 2400
Phone: 18019725000
Varex Imaging Corp. engages in the design, manufacture, and sale of imaging components. The company is headquartered in Salt Lake City, Utah and currently employs 2,400 full-time employees. The company went IPO on 2017-01-20. The Company’s segments include Medical and Industrial. Its Medical segment designs, manufactures, sells and services X-ray imaging components, including X-ray tubes, flat panel and photon-counting detectors and accessories, high-voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and coolers. Its Industrial segment designs, develops, manufactures, sells, and services X-ray imaging products for use in a number of applications, including security applications for cargo screening at ports and borders, baggage screening at airports, and nondestructive testing, irradiation, and inspection applications used in a number of other verticals.
The current stock price of VREX is 10.81 USD. The price decreased by -0.46% in the last trading session.
VREX does not pay a dividend.
VREX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
VREX stock is listed on the Nasdaq exchange.
VAREX IMAGING CORP (VREX) will report earnings on 2026-05-06.